GHRS
Price
$12.60
Change
-$0.18 (-1.41%)
Updated
Dec 26 closing price
Capitalization
781.57M
61 days until earnings call
Intraday BUY SELL Signals
IVVD
Price
$2.69
Change
-$0.12 (-4.27%)
Updated
Dec 26 closing price
Capitalization
745.3M
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GHRS vs IVVD

Header iconGHRS vs IVVD Comparison
Open Charts GHRS vs IVVDBanner chart's image
GH Research
Price$12.60
Change-$0.18 (-1.41%)
Volume$148.09K
Capitalization781.57M
Invivyd
Price$2.69
Change-$0.12 (-4.27%)
Volume$2.38M
Capitalization745.3M
GHRS vs IVVD Comparison Chart in %
GHRS
Daily Signal:
Gain/Loss:
IVVD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GHRS vs. IVVD commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Buy and IVVD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (GHRS: $12.60 vs. IVVD: $2.69)
Brand notoriety: GHRS and IVVD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 46% vs. IVVD: 30%
Market capitalization -- GHRS: $781.57M vs. IVVD: $745.3M
GHRS [@Biotechnology] is valued at $781.57M. IVVD’s [@Biotechnology] market capitalization is $745.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 1 FA rating(s) are green whileIVVD’s FA Score has 0 green FA rating(s).

  • GHRS’s FA Score: 1 green, 4 red.
  • IVVD’s FA Score: 0 green, 5 red.
According to our system of comparison, IVVD is a better buy in the long-term than GHRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 4 TA indicator(s) are bullish while IVVD’s TA Score has 3 bullish TA indicator(s).

  • GHRS’s TA Score: 4 bullish, 5 bearish.
  • IVVD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both GHRS and IVVD are a bad buy in the short-term.

Price Growth

GHRS (@Biotechnology) experienced а -2.78% price change this week, while IVVD (@Biotechnology) price change was +16.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

GHRS is expected to report earnings on Feb 26, 2026.

IVVD is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($782M) and IVVD($745M) have the same market capitalization . IVVD YTD gains are higher at: 507.086 vs. GHRS (80.000). GHRS has higher annual earnings (EBITDA): -42.56M vs. IVVD (-59.05M). GHRS has more cash in the bank: 289M vs. IVVD (85M). GHRS has less debt than IVVD: GHRS (582K) vs IVVD (2.68M). IVVD has higher revenues than GHRS: IVVD (50M) vs GHRS (0).
GHRSIVVDGHRS / IVVD
Capitalization782M745M105%
EBITDA-42.56M-59.05M72%
Gain YTD80.000507.08616%
P/E RatioN/AN/A-
Revenue050M-
Total Cash289M85M340%
Total Debt582K2.68M22%
TECHNICAL ANALYSIS
Technical Analysis
GHRSIVVD
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signal:
Gain/Loss:
IVVD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGGNX33.090.44
+1.35%
American Century Global Gold I
BGSCX52.320.13
+0.25%
BlackRock Technology Opportunities Inv C
SLCAX13.18N/A
N/A
SEI Large Cap A (SIIT)
ARTHX22.44N/A
N/A
Artisan Global Equity Investor
RYHIX139.71-0.03
-0.02%
Rydex Health Care Inv

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-1.45%
MDGL - GHRS
43%
Loosely correlated
-0.65%
IVVD - GHRS
35%
Loosely correlated
-4.27%
ATAI - GHRS
35%
Loosely correlated
-2.86%
HCWB - GHRS
33%
Poorly correlated
-4.38%
IBRX - GHRS
31%
Poorly correlated
N/A
More

IVVD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVVD has been loosely correlated with VIR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IVVD jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVVD
1D Price
Change %
IVVD100%
-4.27%
VIR - IVVD
37%
Loosely correlated
-1.80%
CDTX - IVVD
36%
Loosely correlated
-0.03%
GHRS - IVVD
36%
Loosely correlated
-1.45%
HCWB - IVVD
35%
Loosely correlated
-4.38%
AXON - IVVD
34%
Loosely correlated
-1.24%
More